Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide)

Additional information

Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide)'s dosage depends on your condition, it is usually given once daily. Your doctor or pharmacist may have suggested a schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often than prescribed. If you miss a dose, contact your pharmacist. It may be taken with or without food. Swallow the whole capsule with a full glass of water.

WARNING: Drugs such as Ramipril can cause injury and death to the developing fetus. Angioedema, a serious allergic reaction that causes the area around the throat and tongue to swell, may occur with Ramipril (especially after the first dose). In black patients, the effects of Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide) may be less pronounced. Ramipril may cause a dry, persistent cough that usually disappears after stopping or decreasing the dose. Use with caution in patients with kidney or liver disease, dose adjustment may be recommended. Hydrochlorothiazide may cause sudden increase in eyes pressure. Symptomatic hypotension (low blood pressure) with or without syncope (fainting or passing out) can occur. These events may occur at anytime during therapy and without warning. 

In addition to its desired action, Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide) may cause some side effects, notably:
It may cause hypotension (low blood pressure), or orthostatic hypotension (low blood pressure that happens when standing up from sitting or lying down). 
It may cause dizziness, flushing, or syncope (fainting).
It may cause nausea, vomiting, fatigue, dizziness, or chest pain. 
It may cause a dry cough and back pain. 

Contraindications: Hypersensitivity (severe allergy) to Ramipril or other ACE inhibitors (similar agents), hydrochlorothiazide, or any component of the formulation, angioedema (swelling of the lip, eyes, and face) related to previous treatment with an ACE inhibitor (similar agents), idiopathic (unknown cause) or hereditary angioedema, concomitant use with Aliskiren in patients with diabetes mellitus (high blood sugar levels), coadministration with or within 36 hours of switching to or from a neprilysin inhibitor (e.g., Sacubitril), pregnancy, breastfeeding.

Taking Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor.

A treatment with Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Taro Ramipril HCTZ (Ramipril Hydrochlorothiazide)